Companion Animal Welfare

Cat Feline Kidney CKD Advanced Monitoring

Advanced CKD monitoring in cats integrates SDMA biomarkers, blood pressure, and quality of life assessment for comprehensive welfare management.

Key Facts

SDMA (symmetric dimethylarginine) detects CKD 4-17 months before creatinine elevation
Staging CKD (IRIS 1-4) guides treatment intensity and monitoring frequency
Blood pressure monitoring is essential at all CKD stages to prevent hypertensive damage
Phosphate management through diet and binders slows CKD progression significantly
Quality of life assessment tools enable objective evaluation of treatment benefit

Welfare Considerations

Advanced CKD monitoring that combines early biomarker detection, blood pressure control, and quality of life assessment provides far better welfare outcomes than waiting for clinical signs. Early detection enables interventions that significantly slow progression and maintain comfort.

What You Can Do

Request SDMA testing alongside creatinine for cats over 7 years at annual wellness checks
Monitor blood pressure regularly for all CKD-diagnosed cats
Use IRIS staging guidelines to ensure your cat receives stage-appropriate treatment